The HRA have launched a consultation on Research Transparency and how this can be improved. This consultation is open between 17 June and 6 September 2019.
The House of Commons Science and Technology Committee published a report in October 2018 on clinical trials transparency as part of an enquiry into research integrity. View the report here.
The concerns which were raised include:
- sponsors failing to register clinical trials
- sponsors failing to update trials registers when studies are finished
- failure to present research results which are accessible to the public
- the erosion of public trust in medicine from failures in clinical trials transparency
The Committee recommended that the HRA should make changes so that it can improve research transparency in the UK.
In response, the HRA formed The Research Transparency Strategy Group.
The Research Transparency Strategy Group have produced a set of plans and proposals which are described here.
These proposals include changes to the process of obtaining Research Ethics Committee approval. As such, it is essential that all stakeholders in health and social care research contribute to the consultation.
The proposals are open for consultation and the HRA requests input from the health and social care research community and members of the public. Read more here.
You can also follow or contribute to discussions on Twitter under the hashtag #MakeItPublic
The consultation opened on 17 June and closes on 6 September 2019.